Ajooni Biotech Limited was originally incorporated as a Private Limited Company with the name Ajooni Biotech Private Limited at Chandigarh on 17th February, 2010. Consequent upon conversion of the ...

Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name ...

a subsidiary of Biovet Pvt Ltd promoted by Dr Ella, has already established a major vaccine manufacturing facility at the Biotech Park in Andharua on the outskirts of the city. Set up with an ...

Shareholders in Bluebird now have a choice of two offers from would-be acquirers Carlyle and SK Capital. Elsewhere, Cytokinetics shared more aficamten data and BridgeBio started a new kind of Attruby ...

Two biotech stocks make perfect candidates for this sort of strategy right now. One has declined over the past four years, while the other just slipped in recent weeks. Each represents a bargain ...

About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

(RTTNews) - Purple Biotech Ltd. (PPBT, PPBT.TA), an Israeli clinical-stage biotechnology company, on Monday announced that it has appointed Shai Lankry as its Chief Financial Officer. Lankry has ...

Purple Biotech Ltd. has appointed Shai Lankry as its new Chief Financial Officer, bringing over 20 years of experience in financial leadership within the biotech and healthcare sectors.

REHOVOT, Israel - Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage biopharmaceutical company with a market capitalization of $6.07 million, today announced the appointment of Shai Lankry ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...